Abstract
Pseudomonas aeruginosa produces a large number of extracellular products which may play a role in pathogenesis. We have used genetic techniques to elucidate the relative contribution of these proteins to virulence, and as a method of producing safe toxoids. A mutant has been isolated which produces an immunologically reactive nontoxic form of toxin A, the most toxic extracellular protein produced by P. aeruginosa. Although there are difficulties in production of sufficient quantities of this CRM toxoid, these are likely to be solved by further genetic manipulation. Protection studies with toxin A antibody and studies of mutants deficient in toxin A have confirmed that toxin A plays a role in pathogenesis while clearly showing that toxin A alone cannot totally account for the virulence of P. aeruginosa. Studies of mutants specifically altered in three other products, exoenzyme S, and the two major proteases of P. aeruginosa, elastase and alkaline protease, have clarified the contribution of these products to virulence. Demonstration by genetic studies that exoenzyme S was a major factor in the virulence for one P. aeruginosa strain allowed us to correctly predict that antibody to this product would be protective against infection with that strain.
This work was supported in part by grant DAMD 17-83-G-9556 from the United States Army and AI 14671 from the National Institute of Allergy and Infectious Disease. TIN was supported by a fellowship from the Natural Sciences and Engineering Research Council of Canada.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Abbreviations
- ADP:
-
adenosine 5′-diphosphate
- NAD:
-
nicotinamide adenine dinucleotide
- CRM:
-
cross reactive antigen.
References
Bjorn, M. J., Iglewski, B. H., Ives, S. K., Sadoff, J. C. and Vasil, M. L., 1978, Effect of iron on yields of exotoxin A in cultures of Pseudomonas aeruginosa PA103, Infect. Immun 19: 785.
Callahan, L. T. III, Martinez, D., Marburg, S., Tolman, R. L. and Galloway, D. R., 1984, Toxoids of Pseudomonas aeruginosa exotoxin A: Photo-affinity inactivation of purified toxin and purified toxin derivatives, Infect. Immun, 43: 1019.
Cryz, S. J., and Iglewski, B. H., 1983, Toxoids of Pseudomonas aeruginosa toxin A: production by chemical and genetic means, Rev. Infect. Dis, 5: S992.
Cryz, S. J., Freidman, R. L. and Iglewski, B. H., 1980, Isolation and characterization of a Pseudomonas aeruginosa mutant producing a non-toxic, immunologically crossreactive toxin A protein, Proc. Natl. Acad. Sci. U.S.A, 77: 7199.
Cryz, S. J., Freidman, R. L., Pavloskis, O. R. and Iglewski, B. H., 1981, Effect of formalin toxoiding on Pseudomonas aeruginosa toxin A:biological, chemical, and immunochemical studies, Infect. Immun, 32: 759.
Cryz, S. J., Furer, E., and Germanier, R. 1983a, Passive protection against Pseudomonas aeruginosa infection in an experimental leukopenic mouse model, Infect. Immun, 40: 659.
Cryz, S. J., Furer, E., and Germanier, R. 1983b, Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide, Infect. Immun, 39: 1072.
Gray, G. L., Smith, D. H., Baldridge, J. S., Harkins, R. N., Vasil, M. L., Ellson, Y., and Heynecker, H. L., 1984, Cloning, nucleotide sequencing and expression in E. coli of the exotoxin A structural gene of Pseudomonas aeruginosa,Proc. Nat. Acad. Sci., (in press).
Doring, G., Obernesser, H. J. and Bozenhart, K., 1981, Extracellular toxins of P. aeruginosa II. Effect of two proteases on human immunoglobulins IgG, IgM and secretory IgA, Zbl. Bakt. Hyg. Mikrobiol, 249: 89.
Howe, T. R. and Iglewski, B. H., 1984, Isolation and characterization of alkaline protease deficient mutants of Pseudomonas aeruginosa in vitro and in a mouse eye model, Infect. Immun, 43: 1058.
Iglewski, B. H. and Kabat D., 1975, NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa exotoxin A, Proc. Natl. Acad. Sci. U.S.A, 72: 2284.
Iglewski, B. H., Sadoff J. C., Bjorn, M. J. and Maxwell, E. S., 1978, Pseudomonas aeruginosa exoenzyme S: an adenosine diphosphate ribosyl- transferase distinct from toxin A, Proc. Natl. Acad. Sci. U.S.A, 75: 3211.
Liu, P. V., 1974, Extracellular toxins of Pseudomonas aeruginosa, J. Infect. Dis., 130: 594.
Liu, P. V. and Hsieh, H., 1973. Exotoxins of Pseudomonas aeruginosa III: Characteristics of exotoxin A, J. Infect. Dis, 128: 520.
Nicas, T. I. and Iglewski, B. H., 1984a, Isolation and characterization of transposon induced mutants of Pseudomonas aeruginosa deficient in exoenzyme S, Infect. Immun. (in press).
Nicas, T. I. and B. H. Iglewski, 1984b, The contribution of exoproducts to virulence of Pseudomonas aeruginosa, Canadian J. Microbiol., (in press).
Ohman, D. E., Burns, R. P. and Iglewski, B. H., 1980a, Corneal infections of mice with toxin A and elastase mutants of Pseudomonas aeruginosa, J. Infect. Dis, 142: 547.
Ohman, D. E., Cryz, S. J. and Iglewski, B. H., 1980b, Isolation and characterization of a Pseudomonas aeruginosa PAO mutant that produces altered elastase, J. Bacteriol, 142: 836.
Ohman, D. E., Sadoff, J. C. and Iglewski, B. H., 1980c, Toxin A deficient mutants of Pseudomonas aeruginosa PA103: Isolation and characterization, Infect. Immun, 28: 899.
Pavlovskis, O. R., Pollack, M., Callahan, L. T. III and Iglewski, B. H., 1977, Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections, Infect. Immun 18: 596.
Pavlovskis, O. R., Edman, D. C., Leppla, S. H., Wretlind, B., Lewis, L. and Martin, K. E., 1981, Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with toxin A, Infect. Immun 24: 181.
Pollack, M. and Prescott, R. K., 1982, Toxoid from exotoxin A of Pseudomonas aeruginosa: preparation and characterization, J. Infect. Dis, 145: 688.
Snell, K., Holder, I. A., Leppla, S. H. and Saelinger, C. B., 1978, Role of exotoxin A and protease as possible virulence factors in experimental infections with Pseudomonas aeruginosa, Infect. Immun, 19: 839.
Sokol, P. A., Iglewski, B. H., Hager, T. A., Sadoff, J. C., Cross, A. S., McManus, A., Farber, B. F., and Iglewski, W. F., 1981, Production of exoenzyme S by clinical isolates of Pseudomonas aeruginosa, Infect. Immun, 34: 147.
Sokol, P. A., Cox, C. D., and Iglewski, B. H., 1982, Pseudomonas aeruginosa mutants altered in their sensitivity to the effect of iron on toxin A or elastase yields. J. Bacteriol 151: 783.
Vasil, D. E., Kabat, D. and Iglewski, B. H., 1977, Structure activity relationships of an exotoxin of Pseudomonas aeruginosa, Infect. Immun, 16: 353.
Walker, H. C., McCleod, G. C., Leppla, S. H., Wretlind, B. and Mason, A. D., 1979, Evaluation of Pseudomonas aeruginosa toxin A in experimental rat burn wound specis, Infect. Immun, 25: 828.
Woods, D. E., and Iglewski, B. H., 1983, Toxins of Pseudomonas aeruginosa: new perspectives, Rev. Infect. Dis, 5: S715.
Wretlind, B. and Pavlovskis, O. R., 1983, Pseudomonas aeruginosa proteases and their role in Pseudomonas infections, Rev. Infect. Dis. 5: S998.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Plenum Press, New York
About this chapter
Cite this chapter
Nicas, T.I., Iglewski, B.H. (1985). Genetic Approaches to Study Pseudomonas Aeruginosa Protein Antigens. In: Atassi, M.Z., Bachrach, H.L. (eds) Immunobiology of Proteins and Peptides—III. Advances in Experimental Medicine and Biology, vol 185. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7974-4_15
Download citation
DOI: https://doi.org/10.1007/978-1-4684-7974-4_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-7976-8
Online ISBN: 978-1-4684-7974-4
eBook Packages: Springer Book Archive